Nivolumab
ONO-4538-38
Phase 3 small_molecule completed
Quick answer
Nivolumab for Gastric Cancer is a Phase 3 program (small_molecule) at Ono Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ono Pharmaceutical Co.,
- Indication
- Gastric Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed